Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: CAR+ T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma that developed in two patients treated on the phase 3 CARTITUDE-4 trial who had evidence of detectable CAR transgene expression and integration.”
“CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma”
Authors: Simon Harrison, Cyrille Touzeau, Nicolas Kint, Benoit Tessoulin, Piers Blombery et al.
More posts featuring Robert Orlowski.
